Making clinical tools from basic research knowledge is a practice Novartis and FMI researchers pursue. Read how they want to help retinitis pigmentosa patients to see the light.

Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.

Jean Silveri shares key insights from her legal career.

The modernization and miniaturization of pharmaceutical production could expand the range of ingredients medicinal chemists use to make new drugs.

Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.

An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.

The word “biopsy” typically conjures images of large needles. Lab technicians—and scientists working to discover new medicines—need enough tissue from a patient to prepare and evaluate a sample.

Melanoma survivor T.J. Sharpe discusses skin cancer prevention and detection, and shares tips on how to keep you and your loved ones safe in the sun.